Abstract
Biobanks are evolving, as is shown by the emergence of what are known as “Next Generation Tumor Biobanks” (NGTB). In addition, some research activities are being dissociated from healthcare (diagnostic, prognostic, targeted therapy, immunotherapy) and from the development of genomic medicine. Many biobanks are taking on new roles, becoming centers of expertise in a wide variety of fields (clinical, pathology, genomics, bio-statistics, bio-informatics, and even mathematics), as well as repositories for the collection and storage of samples.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Clément, B., Hofman, P., Desille, M., & Dagher, G. (2017). Réalités industrielles. La normalisation des techniques d’ingénierie en recherche biomédicale: l’exemple des centres de ressources biologiques. Annales des Mines, 2, 24–28.
Clément, B., Yuille, M., Zaltoukal, K., Wichmann, H. E., Anton, G., Parodi, B., et al. (2014). EU-US expert group on cost recovery in biobanks. Public biobanks: Calculation and recovery of costs. Science Translational Medicine, 6(261), 261fs45.
Cooreman, A., Bravo, E., van Gool, A. J., Puchois, P., Roehrl, H. A., & Hofman, P. (2017). Traceability and transparency should be mandatory for all human biospecimens. Applied Clinical Trials, 2, 1–7.
Doucet, M., Becker, K. F., Björkman, J., Bonnet, J., Clément, B., Daidone, M. G., et al. (2016). Quality matters: 2016 annual conference of the National Infrastructures for biobanking. Biopreservation and Biobanking, 15, 270–276.
Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015). The economics of reproducibility in preclinical research. PLoS Biology, 13(6), e1002165.
Gormally, E., Hardy, I., Caboux, E., Di Donato, J. H., Hainaut, P., & Hofman, P. (2017). Training the next generation of biobankers: A two-years Master’s course in the management of biobanks. Biopreservation and Biobanking, 15(5), 438–450.
Henderson, M. K., Goldring, K., & Simeon-Dubach, D. (2017). Achieving and maintaining sustainability in biobanking through business planning, marketing, and access. Biopreservation and Biobanking, 15(1), 1–2.
Hofman, V., Ilie, M., Long, E., Washetine, K., Chabannon, C., Figarella-Branger, D., et al. (2013). Measuring the contribution of tumor biobanks to research in oncology: Surrogate indicators and bibliographic output. Biopreservation and Biobanking, 11(4), 235–244.
Hofman, P. (2006). The CHU-CRLCC-UNSA tumour/tissue bank of the nice area. Medical Science (Paris), 22(1), 21–25.
Hofman, V., Bonnetaud, C., Gaziello, M. C., Ilie, M., Lassalle, S., Butori, C., et al. (2010). The nice CHU biobank experience to collect patients’ informed consent for research context (2004-2009). Annales de Pathologie, 30(5), 337–343.
Hofman, P., Bréchot, C., Zatloukal, K., Dagher, G., & Clément, B. (2014). Public-private relationships in biobanking: A still underestimated key component of open innovation. Virchows Archiv, 464(1), 3–9.
http://www.rfidjournal.com/article/view8303. French biobank secure specimens.
Ilie, M., Szafer-Glusman, E., Hofman, V., Long-Mira, E., Suttmann, R., Darbonne, W., et al. (2017). Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients. Oncotarget, 8, 26112–26121.
Ilie, M., Nunes, M., Blot, L., Hofman, V., Long-Mira, E., Butori, C., et al. (2015). Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps. Cancer Medicine, 4(2), 201–211.
Long, E., Hofman, V., Ilie, M., Washetine, K., Lespinet, V., Bonnetaud, C., et al. (2013). Accreditation of the activity of molecular pathology according to ISO 15189: Key steps to follow and the main potential pitfalls. Annales de Pathologie, 33(1), 12–23.
Long-Mira, E., Washetine, K., & Hofman, P. (2016). Sense and nonsense in the process of accreditation of a pathology laboratory. Virchows Archiv, 468(1), 43–49.
Lassalle, S., Hofman, V., Ilie, M., Butori, C., Bonnetaud, C., Gaziello, M. C., et al. (2011). Setting up a prospective thyroid biobank for translational research: Practical approach of a single institution (2004-2009, Pasteur hospital, nice, France). Biopreservation and Biobanking, 9(1), 9–19.
Mabile, L., Dalgleish, R., Thorisson, G. A., Deschênes, M., Hewitt, R., Carpenter, J., et al. (2013). BRIF working group: Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience., 2(1), 7.
Macheiner, T., Huppertz, B., Bayer, M., & Sargsyan, K. (2017). Challenges and driving forces for business plans in biobanking. Biopreservation and Biobanking, 15(2), 121–125.
Rakha, E., Pajares, M. J., Ilie, M., Pio, R., Echeveste, J., Hughes, E., et al. (2015). Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators. European Journal of Cancer, 51(14), 1897–1903.
Washetine, K., Ilié, I., Hofman, P., Butori, C., Long, E., Lassalle, S., et al. (2017a). Les biobanques : quels enjeux en 2017 ? Revue Francophone Des Laboratoires, 448, 25–28.
Washetine, K., Hofman, V., Lassalle, S., Long, E., Ilié, M., Butori, C., et al. (2017b). L’accréditation des laboratoires d’ACP : pourquoi est-ce incontournable? Revue Francophone Des Laboratoires, 448, 31–37.
Yuille, M., van Ommen, G. J., Bréchot, C., Cambon-Thomsen, A., Dagher, G., Landegren, U., et al. (2008). Biobanking for Europe. Briefings in Bioinformatics, 9(1), 14–24.
Yuille, M. M., Feller, P. I., Georghiou, L., Laredo, P., & Welch, E. W. (2017). Financial sustainability of biobanks: From theory to practice. Biopreservation and Biobanking, 15(2), 85–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Hofman, P. (2018). The Policies of Tumor Biobankers: Main Strategies and an Example of the Policies Adopted by the Nice Hospital Biobank, France. In: Bioy, X. (eds) Public Regulation of Tumor Banks. Springer, Cham. https://doi.org/10.1007/978-3-319-90563-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-90563-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90562-4
Online ISBN: 978-3-319-90563-1
eBook Packages: Law and CriminologyLaw and Criminology (R0)